What We’re Reading: Respiratory Illnesses Strain Hospitals; Pfizer Booster Addresses Omicron Subtypes; Audits Reveal MA Overcharges
Covid, flu, and respiratory syncytial virus are overwhelming hospitals across the nation; Pfizer claims its new booster may give protection against new subvariants of the COVID-19 Omicron variant; federal audits reveal overcharges and other payment errors in Medicare Advantage (MA) plans.
Respiratory Illnesses Overwhelm Hospitals
Respiratory illnesses, such as respiratory syncytial virus, COVID-19, and the flu, are a major factor in hospitals across the country feeling overwhelmed and filling at a faster rate, according to
New COVID-19 Booster May Be Effective Against New Variants
Pfizer claims that its updated booster for COVID-19 may be able to protect boosted individuals from new Omicron mutations, according to
Federal Audits Reveal Medicare Advantage Overcharges
Newly released federal audits revealed that payments for Medicare Advantage health plans included overcharges and other errors, according to
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Related Articles
- Promising Early Efgartigimod Response Data for Generalized Myasthenia Gravis
September 18th 2025
- Metabolic Issues More Common in Patients With HIV
September 18th 2025
- Barriers to Gender-Affirming Surgery Persist Despite High Satisfaction Rate
September 18th 2025
- Eating Behaviors May Predict GLP-1 Therapy Success in Type 2 Diabetes
September 18th 2025